ArticleRheumatology (Oxford, England)2022

Safety of third-dose SARS-CoV-2 vaccination in patients with rheumatic and musculoskeletal disease.

Caoilfhionn M Connolly et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.